Erqi Wang - JIN MEDICAL President Board
| ZJYL Stock | 0.83 0.07 7.78% |
President
Erqi Wang is President Board of JIN MEDICAL INTERNATIONAL
| Age | 55 |
| Address | No. 33 Lingxiang Road, Changzhou, China |
| Phone | 86 51 9896 07972 |
| Web | https://www.zhjmedical.com |
JIN MEDICAL Management Efficiency
The company has return on total asset (ROA) of 0.0403 % which means that it generated a profit of $0.0403 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1133 %, meaning that it created $0.1133 on every $100 dollars invested by stockholders. JIN MEDICAL's management efficiency ratios could be used to measure how well JIN MEDICAL manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.14 this year. Return On Capital Employed is expected to rise to 0.26 this year. At this time, JIN MEDICAL's Return On Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.92 this year, although the value of Net Tangible Assets will most likely fall to about 13.8 M.Similar Executives
| Found 14 records | PRESIDENT Age | ||
| Bernard Duc | BCE Inc | 46 | |
| David GranvilleSmith | Sphere Entertainment Co | 58 | |
| Glen LeBlanc | BCE Inc | 44 | |
| Rizwan Jamal | BCE Inc | N/A | |
| Blaik Kirby | BCE Inc | N/A | |
| Jennifer Koester | Sphere Entertainment Co | N/A | |
| Randy Lennox | BCE Inc | N/A | |
| John Watson | BCE Inc | 61 | |
| Claire Gillies | BCE Inc | N/A | |
| Sean Cohan | BCE Inc | 49 | |
| Thomas Little | BCE Inc | N/A | |
| Michael Cole | BCE Inc | N/A | |
| Andrea Greenberg | Sphere Entertainment Co | 66 | |
| Thane Fotopoulos | BCE Inc | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0403 |
JIN MEDICAL INTERNATIONAL Leadership Team
Elected by the shareholders, the JIN MEDICAL's board of directors comprises two types of representatives: JIN MEDICAL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of JIN. The board's role is to monitor JIN MEDICAL's management team and ensure that shareholders' interests are well served. JIN MEDICAL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, JIN MEDICAL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ziqiang Wang, CFO Director | ||
| Erqi Wang, President Board |
JIN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is JIN MEDICAL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0403 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 114.78 M | ||||
| Shares Outstanding | 156.55 M | ||||
| Shares Owned By Insiders | 75.84 % | ||||
| Shares Owned By Institutions | 1.14 % | ||||
| Number Of Shares Shorted | 920.44 K | ||||
| Price To Book | 4.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.03 | Return On Assets |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.